IRIS Media Inc: Clinical Trials

5 trials sponsored by IRIS Media Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting. 3 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 22Completed 1, Not yet recruiting 1

Follow IRIS Media Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Putting Children First - Parent Training for Parents in High Conflict
Putting Children First - Parenting Behavior, Parent Management Training
Phase 2Not yet recruitingIRIS Media Inc5002026-03-012025-02-05
Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
Best Practice, Comparator Program, Best Practice, Usual Care, Internet-Based Intervention - Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm
Not applicableCompletedMayo Clinic3482025-06-052026-08-18
Personal Relevance of Psychotherapy for Asian Americans
MindBoba, Mindshift CBT - Behavior, Stress
Phase 2CompletedIRIS Media Inc2632024-05-012026-08-05
Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)
Mindful You mobile app - Behavior
Not applicableCompletedIRIS Media Inc2122021-02-012022-06-23
ASD Parent Trainer: Online Coaching for Parents of Children With Autism
Autism Parent Trainer (APT), Teaching Routines (Control) - Autism Disorder
Not applicableCompletedIRIS Media Inc1562016-08-012020-02-05

Conditions studied

Behavior (2)  ·  Anxiety Disorders (1)  ·  Autistic Disorder (1)  ·  Child Behavior (1)  ·  Emotional Regulation (1)

Interventions

Massage (1)  ·  Practice Guidelines as Topic (1)  ·  Standard of Care (1)

Countries

United States (4)

Top investigators

Cindy Tofthagen, PhD, RN (1)  ·  Meme Hieneman, Ph.D., BCBA (1)  ·  Nell Caraway, BA (1)  ·  William Collinge, PhD, MPH (1)

NIH funding

R43CA268678 (1)